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Background. Infections increase the risk of ischemic stroke (IS) and may worsen IS prognosis. Adverse eﬀects of in-hospital
infections on stroke outcome were also reported. We aimed to study the prevalence of pre- and poststroke infections and their
impact on IS outcome. Methods. We analysed clinical data of 2066 IS patients to assess the eﬀe c to fp r e - s t r o k ea n dp o s t - s t r o k e
infections on IS severity, as well as short-term (up to 30 days) and long-term (90 days) outcome. The independent impact
of infections on poor outcome (death, death/dependency) was investigated by use of logistic regression analysis. The eﬀect of
antibiotic therapy during hospitalization on the outcome was also assessed. Results. Pre-stroke infections independently predicted
worseshort-termoutcome.In-hospitalinfectionswereassociatedwithworseshort-termandlong-termISprognosis.Antibacterial
treatment during hospitalization did not improve patients’ outcome. Conclusions. Prevention of infections may improve IS
prognosis. The role of antibiotic therapy after IS requires further investigations.
1.Introduction
Infections preceding the ischemic stroke (IS), as well as
infections occurring in the acute phase of IS, are a frequent
phenomenon [1, 2]. Chronic infections of both viral and
bacterial etiology and coexistent vascular inﬂammatory
state promote atherosclerosis, contributing to an increased
cerebrovascular risk [3,4].Theassociationofprestrokeacute
infectious events, in particular, respiratory tract infections,
with increased risk of stroke [5], especially of cardioembolic
and atherothrombotic etiology, was reported [2, 6]. Some
authors suggest that prestroke infections are related not
only to the risk but also to IS severity [7, 8]. On the
other hand, stroke severity and lesion location are associated
with the risk of in-hospital (post-stroke) infections. For
example, patients with brainstem or diﬀuse cerebral lesions
characterize with an increased risk of respiratory tract
infection, that frequently results from dysphagia [9, 10]. It
seemspossiblethatpost-strokeinfectiouseventsarefavoured
by the stroke-induced immunodepression [2].
The impact of post-stroke infections on IS outcome
is the next important issue [11]. Some authors describe
an association of post-stroke infections with poor patients’
outcome [12–14].
According to the presented data, a proper treatment of
stroke-related infections may improve patients’ outcome.
Until now some reports suggest that therapy with antibiotics
in the acute phase of stroke (even in patients without the
obvious signs of infection) reduces cerebral ischemia and
improves the outcome [15, 16]. However, these observations
were not conﬁrmed by other studies [17, 18]. Some authors
hypothesized that the use of antibiotics or vaccines before
stroke onset may improve outcome [19].
The aims of our study were to investigate the preva-
lence of prestroke (occurring during 7 days before hospital
admission) and post-stroke (in-hospital) infections among
IS patients hospitalized in our stroke unit, as well as to
analyse the impact of infections on stroke severity and the
outcome, in terms of mortality and dependency during 3
months after IS.
2. Methods
We analyzed the clinical data of patients hospitalized in
our department between June 1, 1995 and August 31, 2005.
The registry included 2066 consecutive patients admitted to
the hospital with symptoms of acute IS. IS was diagnosed
according to the World Health Organization deﬁnition as2 Neurology Research International
Table 1: Characteristics of patients with or without prestroke infection.
Characteristics Prestroke infection (n = 111) No prestroke infection (n = 1839)
P N Value N Value
Baseline characteristics
Age, mean, SD (years) 111 74.6 ± 11.8 1834 71.5 ± 12.3 .010
Gender (male), n (%) 111 49 (44.1) 1839 843 (45.8) .769
Premorbid mRS 3–5, n (%) 111 17 (15.3) 1833 178 (9.7) .071
History of stroke, n (%) 110 18 (16.4) 1818 283 (15.6) .788
Hypertension, n (%) 109 74 (67.9) 1830 1353 (73.9) .179
Atrial ﬁbrillation, n (%) 110 30 (27.3) 1824 513 (28.1) .913
Heart failure, n (%) 109 37 (33.9) 1814 417 (23.0) .014
CAD, n (%) 110 43 (39.1) 1825 646 (35.4) .473
Diabetes, n (%) 111 25 (22.5) 1823 397 (21.8) .814
Nicotine use (5 years), n (%) 107 21 (19.6) 1822 476 (26.1) .141
Etiology of IS (TOAST)
111 1839 Atherothrombotic, n (%) 16 (14.4) 291 (15.8) .789
Cardioembolic, n (%) 28 (25.2) 484 (26.3) .912
Lacunar, n (%) 16 (14.4) 343 (18.7) .313
Diﬀuse lesion (≥1 lobe) 82 33 (40.2) 1110 384 (34.6) .337
TACI, n (%) 110 26 (23.6) 1830 306 (16.7) .068
Admission SSS, mean, SD 111 29.2 ± 18.0 1836 34.0 ± 17.3 .008
Body temperature day 1, mean (◦C) 100 36.8 ± 0.58 1724 36.7 ± 0.43 .033
Mean week body temperature (◦C) 80 36.9 ± 0.34 1432 36.8 ± 0.36 .038
Outcome
Recurrent stroke, n (%) 111 1 (0.9) 1837 29 (1.6) .573
30-day SSS, mean, SD 80 43.9 ± 13.9 1564 46.1 ± 13.4 .157
30-day mortality, n (%) 111 34 (30.6) 1839 281 (15.3) <.001
30-day death or dependency, n (%) 111 76 (68.5) 1809 957 (52.9) .002
90-day mortality, n (%) 95 39 (41.1) 1601 404 (25.2) .001
90 day death or dependency, n (%) 88 54 (61.4) 1514 743 (49.1) .028
N: the number of patients with available data; SD: standard deviation; mRS: modiﬁed Rankin Scale; CAD: coronary artery disease; TACI: total anterior
circulation infarction; IS: ischemic stroke; TOAST: Trial of Org 10172 in Acute Stroke Treatment; SSS: Scandinavian Stroke Scale.
rapidly developed clinical signs of cerebral function distur-
bance lasting for more than 24 hours, of a vascular origin
[20]. Brain imaging (CT, computed tomography or MRI,
magnetic resonance imaging) was performed to conﬁrm the
diagnosis of IS. Information about stroke risk factors and
clinical data was collected according to the modiﬁed Stroke
DataBankNINCDSprotocol[21]includingdataon:ageand
gender, history of hypertension, diabetes, atrial ﬁbrillation,
coronary artery disease (CAD), heart failure and stroke,
nicotine use during last 5 years, premorbid handicap status
(dependency), neurological status on admission, etiology of
IS, clinical stroke syndromes, volume of ischemic lesion, as
well as infectious events during 7 days before admission,
occurrence of pneumonia, and urinary tract infection (UTI)
during hospitalization and the use of antibiotics during
hospitalization.
Baseline neurological status and premorbid functional
impairment were evaluated using the Scandinavian Stroke
Scale (SSS) (score 0–58) [22] and modiﬁed Rankin Scale
(mRS) (score 0–5) [23].
Information about prestroke factorswas obtained during
direct interview with patients. In case of unconscious,
drowsy, or demented patients, their close relatives were
interviewed. The information was supported by medical
reports, if available. The history of prestroke infection
included reported signs of an acute infectious disease (such
as cold, fever, cough, or dysuria), medical reports on such
a condition, as well as the use of antibacterial, antiviral, or
supportive therapy and laboratory ﬁndings obtained during
preceding 7 days that were typical for an acute infection. In
our database information on the type of prestroke infection,
as well as on classes of antibiotics used prior to IS, is not
collected, thus, we did not analyse such data.
The etiology of IS was determined according to the
criteria developed for the Trial of Org 10172 in Acute
Stroke Treatment [24] on the basis of results of extra- and
intracranial arteries ultrasonography, echocardiography, and
electrocardiography. The ﬁve categories of IS were isolated
according to etiology, that is, (1) large artery atherosclerosis,
(2) cardioembolism, (3) small artery occlusion, (4) otherNeurology Research International 3
determined etiology, and (5) unknown or multiple etiolo-
gies. In addition, using clinical criteria of the Oxfordshire
Community Stroke Project (OCSP) based on neurological
signs and syndromes, subtypes of IS were classiﬁed into
total anterior circulation infarction (TACI), partial anterior
circulation infarction (PACI), lacunar (LACI) and posterior
circulation infarction (POCI) [25].
The diagnosis of pneumonia during hospitalization was
established according to the CDC criteria for hospital-acqui-
red pneumonia [26], on a basis of clinical and laboratory
indices of respiratory tract infection (fever, cough, ausculta-
tory changes, purulent tracheal secretions, positive sputum
culture), supported by typical chest X-ray ﬁndings. The
in-hospital UTI was diagnosed on a basis of leukocyturia
present in the urine examination and positive urine cul-
ture (signiﬁcant bacteriuria ≥105/mL with isolation of a
pathogen), supported by clinical symptoms, such as dysuria,
urgency, or fever [26].
The SSS and mRS assessments were repeated at discharge
or (if patient needed longer hospitalization) at the 30th day
of hospital stay. The mRS score was also assessed 90 days
after stroke.
The short-term (assessed at discharge or at the 30th day
of hospital stay) and long-term (assessed 90 days after IS
onset) outcomes were analysed. The outcome measurements
included (1) mortality; (2) death or dependency (mRS ≥ 3).
Poor outcome was deﬁned as death or death/dependency. In
case of death within 90 days from the hospital admission,
the date and reason were registered. The following causes
of death were registered in the studied group: neurological
complications (IS or recurrent stroke), cardiogenic reasons
or pulmonary embolus, infectious complications, and oth-
ers, not related to stroke.
2.1. Statistical Analysis. The groups of patients with or with-
outthehistoryofprestrokeinfectionwerecomparedinterms
of prevalence of IS risk factors, premorbid handicap level
(mRS),baselineclinicalcharacteristics(ISetiologyaccording
to the TOAST criteria, clinical syndromes determined by the
OCSP criteria, neurological status determined by the SSS
score, body temperature recorded during ﬁrst 24 hours, and
7d a y sm e a nb o d yt e m p e r a t u r e ) .T h eg r o u p so fp a t i e n t sw e r e
also compared for stroke recurrence during hospitalization,
for 30-day neurological status, as well as for short-term and
long-term outcome. Similar comparisons was made between
the groups of patients, in whom pneumonia or UTI were
diagnosed after IS, and without any concomitant (prestroke)
infection.
Theimpactofprestrokeandpost-strokeinfectionsonthe
short-term and long-term outcome (in terms of death and
death/dependency) was investigated.
Categorical variables were compared by the use of
Pearson χ2 test. The normality of continuous variables was
determined by the Kolmogorow-Smirnov test. Normally
distributed continuous variables were compared using the
Student’s t-test, and continuous variables with not normal
distribution were compared with the Mann-Whitney U test.
The mRS and SSS were evaluated by the χ2 test, after
dichotomizing the scales into categories: 0–2 and 3–5 points
for the mRS, 0–25 and 26–58 points for the SSS, as it was
accepted in previous studies [27, 28].
For the outcome measures (short- and long-term death
and death/dependency) we did the Pearson χ2 tests to
evaluate diﬀerences between analysed groups. The logistic
regression was used to assess a predictive value of prestroke
and post-stroke infections for the outcome. Logistic regres-
sion analyses were performed, with adjustment for base-
line and clinical variables. Variables that were signiﬁcantly
associated with a given outcome in univariate analysis were
further included in the multivariate models. The odds ratios
with 95% conﬁdence intervals were used to estimate the
magnitude of each factor eﬀect.
Results were thought statistically signiﬁcant when the P
value was lower than .05. Statistical analyses were performed
using SPSS for Windows software, version 13.
3. Results
Among 1950 patients for whom the necessary data was
available, 111 (5.7%) had a history of an acute infection
during 7 days before hospital admission.
Patients who suﬀered from an infectious disease prior to
IS onset were characterized by older age, higher prevalence
of heart failure, as well as by worse neurological status
on hospital admission (Table 1). The prestroke infection
was not related to the type of IS according to the TOAST
criteria, nor to the volume of brain ischemic lesion. Patients
with infection preceding stroke onset were characterized by
poorer short- and long-term outcome in terms of death as
well as of death/dependency, compared with those without
infection (Table 1).
30.6% versus 15.3% of patients with versus without
prestroke infection, respectively, died during 30 days after
stroke onset; the percentage of patients with/without pre-
stroke infection who died within 90 days was 41.1%/25.2%,
respectively. The poor short-term outcome in terms of
death/dependency was noticed in 68.5% of patients with
and in 52.9% of patients without prestroke infection; the
poor long-term outcome was observed in 61.4% of patients
with infection and in 49.1% of patients without prestroke
infection (Table 1).
Among individuals with prestroke infection who died
during the ﬁrst 30 days the cardiogenic cause of death was
diagnosedmorefrequentlythaninpatientswithoutinfection
(36.7% and 19.1%, resp.; P = .033).
Logistic regression analysis revealed that the history
of prestroke infection was an independent predictor of
poor short-term outcome in terms of death and of
death/dependency (Table 3); the prestroke infection was not
a signiﬁcant predictor of long-term outcome.
We observed a higher frequency of in-hospital infections
(pneumonia or UTI) in patients, who suﬀered from any
infection during 7 days prior to hospital admission, com-
paredtothegroupwithoutprestrokeinfection(58.6%versus
33.7%, resp.); P<. 001. About 81% of patients with any
prestroke infection developed in-hospital pneumonia.
During hospitalization, nosocomial pneumonia was
diagnosed in 403 (19.5% of 2066) patients and UTI in 4824 Neurology Research International
Table 2: Characteristics of patients with or without an in-hospital infection.
Characteristics Pneumonia or UTI (n = 619) No infection (n = 1219)
P N Value N Value
Baseline characteristics
Age, mean, SD (years) 618 76.1 ± 10.6 1215 69.2 ± 12.4 <.001
Gender (male), n (%) 619 201 (32.5) 1219 641 (52.6) <.001
Premorbid mRS 3–5, n (%) 616 95 (15.4) 1216 83 (6.8) <.001
History of stroke, n (%) 614 114 (18.6) 1203 169 (14.0) .014
Hypertension, n (%) 614 456 (74.3) 1215 896 (73.7) .822
Atrial ﬁbrillation, n (%) 613 234 (38.2) 1210 279 (23.1) <.001
Heart failure, n (%) 604 193 (32.0) 1209 223 (18.4) <.001
CAD, n (%) 613 247 (40.3) 1211 398 (32.9) .002
Diabetes, n (%) 613 158 (25.8) 1209 239 (19.8) .004
Nicotine use (5 years), n (%) 615 125 (20.3) 1206 351 (29.1) <.001
Etiology of IS (TOAST)
616 1213 Atherothrombotic, n (%) 93 (15.1) 114 (9.4) .543
Cardioembolic, n (%) 209 (33.9) 275 (22.7) <.001
Lacunar, n (%) 61 (9.9) 282 (23.2) <.001
Diﬀuse lesion (≥1 lobe) 408 211 (51.7) 701 173 (24.7) <.001
TACI, n (%) 616 192 (31.2) 1213 114 (9.4) <.001
Admission SSS, mean, SD 617 23.4 ± 16.1 1218 39.3 ± 15.4 <.001
Body temperature day 1, mean (◦C) 574 36.8 ± 0.52 1149 36.7 ± 0.37 <.001
Mean week body temperature (◦C) 616 36.9 ± 1.27 1208 36.7 ± 0.79 <.001
Outcome
Recurrent stroke, n (%) 619 14 (2.3) 1219 15 (1.2) .113
30-day SSS, mean, SD 424 36.7 ± 15.9 1139 49.6 ± 10.3 <.001
30-day mortality, n (%) 619 192 (31.0) 1219 89 (7.3) <.001
30-day death or dependency, n (%) 599 504 (84.1) 1209 453 (37.5) <.001
90-day mortality, n (%) 534 274 (51.3) 1066 130 (12.2) <.001
90-day death or dependency, n (%) 502 405 (80.7) 1011 338 (33.4) <.001
UTI: urinary tract infection; N: the number of patients with available data; SD: standard deviation; mRS: modiﬁed Rankin Scale; CAD: coronary artery
disease; TACI: total anterior circulation infarction; IS: ischemic stroke; TOAST: Trial of Org 10172 in Acute Stroke Treatment; SSS: Scandinavian Stroke Scale.
(23.3%)patients;in154(7.5%)patientsbothinfectionswere
diagnosed.
368 (91.3%) patients with pneumonia, 441 (91.5%)
patients with UTI, and 133 (86.4%) with both conditions, all
with a negative history of prestroke infection, were further
analysed.
Patients with in-hospital infection (pneumonia or UTI,
n = 619) were characterized by older age, higher percentage
of females, more frequent history of stroke, atrial ﬁbrillation,
heart failure, CAD and diabetes, than patients without
diagnosed infection (Table 2). The post-stroke pneumonia
or UTI developed in patients that were characterized by
worsepremorbidfunctionalstatusandbyworseneurological
status on admission. The in-hospital infections occurred
more frequently in patients presenting with TACI and with
ischemic lesions occupying at least one lobe of the brain
(Table 2).
In-hospital pneumonia more frequently developed
among patients with dysphagia (92; 86.8% of 106 patients),
than in those without swallowing diﬃculties (267; 48.2% of
554 patients); (P<. 001).
In patients with in-hospital infection (pneumonia or
UTI) the cardioembolic etiology of stroke was diagnosed
more often; lacunar strokes were diagnosed less frequently,
compared to patients without an infection (Table 2).
The in-hospital infection was associated with a worse
neurological status assessed at hospital discharge/30 days
after admission; it was also related to worse short-
term and long-term outcome in terms of death and of
death/dependency (Table 2).
Weobservednoinﬂuenceofin-hospitalinfectionsonthe
prevalence of recurrent stroke during the hospitalization.
The regression analysis was performed to assess the
impact of pneumonia, UTI, or of both coexisting conditions,
on patients’ outcome (Tables 4 and 5). The in-hospital
pneumonia was independently associated with the risk of
poor short-term and long-term outcome. The in-hospital
UTI was independently associated with poor short- andNeurology Research International 5
Table 3: Logistic regression for poor 30-days outcome (prestroke infection).
Variables OR 95% CI P
Death
Prestroke infection 2.086 1.323–3.288 .002
Age 1.036 1.023–1.050 <.001
Gender (male) 0.934 0.709–1.230 .627
mRS 3–5 before stroke 1.191 1.078–1.317 .001
Heart failure 2.038 1.516–2.740 <.001
Atrial ﬁbrillation 1.413 1.065–1.876 .017
Diabetes mellitus 1.296 0.963–1.745 .087
CAD 0.912 0.688–1.208 .519
Death or dependency
Prestroke infection 1.635 1.044–2.560 .032
Age 1.027 1.018–1.037 <.001
Gender (male) 0.807 0.657–0.992 .041
mRS 3–5 before stroke 1.963 1.728–2.230 <.001
History of stroke 0.904 0.666–1.227 .519
Heart failure 1.198 0.916–1.566 .187
Atrial ﬁbrillation 1.345 1.053–1.716 .017
Diabetes mellitus 1.231 0.962–1.574 .098
CAD 1.081 0.865–1.351 .492
OR: odds ratio; CI: conﬁdence interval; mRS: modiﬁed Rankin Scale; CAD: coronary artery disease.
Table 4: Logistic regression for poor 30-day outcome (in-hospital infections).
Variables Pneumonia UTI Pneumonia and UTI
OR 95% CI P OR 95% CI P OR 95% CI P
Death
Pneumonia 5.422 3.684–7.979 <.001 — — — — — —
UTI — — — 0.551 0.353–0.859 .009 — — —
Pneumonia and UTI — — — — — — 2.275 1.454–3.559 <.001
Age 1.028 1.012–1.044 <.001 1.038 1.022–1.054 <.001 1.037 1.021–1.052 <.001
Gender (male) 0.850 0.605–1.194 .350 0.912 0.656–1.266 .581 0.987 0.711–1.371 .939
mRS 3–5 before stroke 1.699 1.093–2.641 .018 1.652 1.073–2.543 .023 1.598 1.043–2.450 .031
Heart failure 2.197 1.527–3.162 <.001 2.079 1.463–2.954 <.001 2.018 1.419–2.870 <.001
Atrial ﬁbrillation 1.143 0.806–1.623 .453 1.206 0.861–1.688 .276 1.193 0.850–1.673 .307
Diabetes mellitus 1.093 0.757–1.576 .636 1.108 0.775–1.584 .574 1.108 0.776–1.583 .574
CAD 0.865 0.611–1.225 .415 0.875 0.625–1.224 .435 0.856 0.612–1.198 .365
Body temperature day 1 1.413 0.968–2.061 .073 1.384 0.958–2.000 .083 1.467 1.017–2.117 .041
Mean week temperature 3.528 2.376–5.238 <.001 4.906 3.334–7.219 <.001 3.963 2.663–5.898 <.001
Death or
dependency
Pneumonia 12.467 6.449–24.102 <.001 — — — — — —
UTI — — — 2.125 1.536–2.942 <.001 — — —
Pneumonia and UTI — — — — — — 20.615 6.385–66.562 <.001
Age 1.027 1.017–1.038 <.001 1.032 1.022–1.042 <.001 1.032 1.022–1.042 <.001
Gender (male) 0.700 0.556–0.882 .002 0.847 0.674–1.063 .152 0.783 0.624–0.981 .034
mRS 3-5 before stroke 17.244 8.495–35.004 <.001 16.536 7.998–34.187 <.001 16.854 8.295–34.241 <.001
Heart failure 1.301 0.960–1.763 .090 1.282 0.952–1.727 .102 1.252 0.926–1.693 .145
Atrial ﬁbrillation 1.152 0.875–1.515 .313 1.185 0.907–1.548 .213 1.138 0.868–1.492 .348
Diabetes mellitus 1.288 0.978–1.696 .071 1.265 0.966–1.657 .088 1.309 0.997–1.719 .052
CAD 1.147 0.894–1.472 .281 1.104 0.864–1.412 .428 1.142 0.891–1.462 .294
Body temperature day 1 1.963 1.391–2.772 <.001 1.895 1.348–2.665 <.001 1.937 1.380–2.719 <.001
Mean week temperature 2.262 1.648–3.105 <.001 2.946 2.089–4.155 <.001 2.288 1.636–3.200 <.001
OR: odds ratio; CI: conﬁdence interval; mRS: modiﬁed Rankin Scale; CAD: coronary artery disease.6 Neurology Research International
Table 5: Logistic regression for poor 90-day outcome (in-hospital infections).
Variables Pneumonia UTI Pneumonia or UTI
OR 95% CI P OR 95% CI P OR 95% CI P
Death
Pneumonia 4.345 2.876–6.564 <.001
UTI 0.756 0.513–1.116 .159
Pneumonia and UTI 5.730 3.399–9.660 <.001
Age 1.043 1.028–1.058 <.001 1.049 1.034–1.064 <.001 1.048 1.033–1.063 <.001
Gender (male) 0.973 0.716–1.322 .861 1.040 0.770–1.404 .800 1.089 0.804–1.477 .582
mRS 3–5 before stroke 2.122 1.365–3.299 .001 2.055 1.328–3.180 .001 2.063 1.328–3.204 .001
Heart failure 2.121 1.503–2.993 <.001 2.036 1.452–2.853 <.001 1.928 1.362–2.730 <.001
Atrial ﬁbrillation 1.357 0.984–1.870 .062 1.406 1.029–1.921 .032 1.367 0.992–1.884 .056
Diabetes mellitus 1.030 0.735–1.443 .865 1.042 0.748–1.451 .808 1.029 0.733–1.443 .870
CAD 0.944 0.687–1.297 .724 0.942 0.690–1.286 .706 0.955 0.694–1.315 .778
Body temperature day 1 1.128 0.770–1.654 .536 1.076 0.738–1.568 .704 1.175 0.799–1.729 .413
Mean week temperature 7.338 4.801–11.216 <.001 10.079 6.595–15.401 <.001 6.766 4.367–10.485 <.001
Death or
dependency
Pneumonia 8.700 4.743–15.956 <.001
UTI 1.517 1.066–2.158 .020
Pneumonia and UTI 8.940 3.975–20.108 <.001
Age 1.035 1.023–1.047 <.001 1.039 1.028–1.051 <.001 1.039 1.027–1.051 <.001
Gender (male) 0.769 0.596–0.992 .043 0.902 0.702–1.159 .419 0.851 0.663–1.092 .205
mRS 3–5 before stroke 8.850 4.648–16.852 <.001 8.206 4.287–15.707 <.001 8.515 4.468–16.228 <.001
Heart failure 1.309 0.941–1.820 .110 1.284 0.930–1.774 .129 1.206 0.868–1.677 .264
Atrial ﬁbrillation 1.259 0.937–1.692 .127 1.275 0.956–1.700 .099 1.241 0.926–1.664 .148
Diabetes mellitus 1.350 1.005–1.813 .046 1.344 1.007–1.794 .045 1.362 1.016–1.826 .039
CAD 1.235 0.939–1.626 .131 1.205 0.920–1.576 .175 1.252 0.954–1.644 .105
Body temperature day 1 1.226 0.838–1.794 .295 1.207 0.834–1.748 .318 1.306 0.898–1.899 .162
Mean week temperature 3.250 2.151–4.908 <.001 4.521 2.969–6.886 <.001 3.238 2.114–4.962 <.001
OR: odds ratio; CI: conﬁdence interval; mRS: modiﬁed Rankin Scale; CAD: coronary artery disease.
long-term outcome in terms of death/dependency; however
it was surprisingly associated with lower short-term mor-
tality. Patients with coexistent pneumonia and UTI had an
increased risk of poor short- and long-term outcomes in
terms of death and of death/dependency (Tables 4 and 5).
The mean body temperature recorded during the ﬁrst 24
hours after admission was signiﬁcantly higher in the group
of patients suﬀering from an acute infection in the preceding
week (Table 1). The body temperature at the ﬁrst day after
admission was signiﬁcantly higher in patients with TACI,
than in patients with other clinical syndromes (36.8◦C ± 0.6
versus 36.7◦C ± 0.4, resp.; P<. 001); the same was noticed
when the mean body temperature in the ﬁrst 7 days after
hospital admission was compared between patients’ groups
with TACI or with other clinical syndromes (37.1◦C ± 0.4
versus 36.8◦C ± 0.3, resp.; P<. 001).
In the regression analysis, increased temperature at the
ﬁrst day of hospital stay was a predictor of increased risk
of death during 30 days in the group of patients with
pneumonia and UTI coexisting; it was also a predictor of
higher risk of short-term death/dependency in all groups
of patients analysed (with pneumonia, UTI or with both
infections) (Table 4).
The increased mean week body temperature was an
independent predictor of poor short-term and long-term
outcomes in all groups of patients analysed (Tables 4 and 5).
In 365 (91.0%) patients with in-hospital pneumonia
antibiotics were used during hospitalization. In this group of
patients, antibacterial therapy had no signiﬁcant impact on
prognosis during the follow-up period. Among patients with
UTI,391(81.8%)weretreatedwithantibiotics.Inthisgroup,
antibacterial therapy was related to poor 30-day outcome
(in terms of death/dependency) that was noticed in 75.5%
of the treated compared to 61.2% of not treated patients
(P = .029).
Among 343 patients (16.6% of 2066), who died within
the30-dayperiod,83(28.4%)diedduetoinfectivecomplica-
tions such as pneumonia or sepsis. The other causes of death
were neurological, cardiogenic or unrelated to stroke. The
presenceofin-hospitalpneumonia,orUTIwasnotrelatedto
death etiology. Patients with coexisting pneumonia and UTI
more frequently died because of infectious complications,
and less often because of neurological complications, than
those without these infections. The treatment with antibi-
otics did not determine the cause of death in patients with
pneumonia, with UTI, as well as with both conditions.Neurology Research International 7
4. Discussion
We provide evidence that prestroke and post-stroke infec-
tions are independent predictors of poor IS outcome. This
ﬁnding is consistent with other reports, which demonstrated
the unfavourable impact of nosocomial infections, especially
pneumonia, on short-term [13] and long-term stroke out-
come [14, 29]. In our study the prestroke infection had an
adverse eﬀect on early outcome, with no eﬀect on long-
term prognosis, while the unfavourable eﬀect of in-hospital
infections (especially of pneumonia and UTI coexisting) was
observed up to 90 days after the IS.
Some authors revealed that an association exists between
prestroke respiratory infections and atherothrombotic and
cardioembolic etiology of IS, as well as with more severe
neurological deﬁcit [30]. In the current study we conﬁrmed
an unfavourable eﬀect of prestroke infections on neurologi-
cal impairment; however, we did not conﬁrm a relationship
between prestroke infection and IS etiology.
The association of infarct volume with in-hospital infec-
tions, particularly the respiratory tract infection, has been
previously described [31]. In the current study we have
observed a similar relationship: patients with in-hospital
pneumonia or UTI were characterized by more diﬀuse isc-
hemic lesions (occupying at least one lobe or TACI). The
relationship between lesion location and respiratory tract
infection was also noticed: pneumonia occured more fre-
quently in patients with dysphagia caused by brainstem or
diﬀuse hemispheric stroke, as it was observed by previous
authors [9, 10].
It was evidenced that high body temperature during ﬁrst
24 hours after stroke onset is associated with large brain
damage [32]. In our population increased body temperature
during the ﬁrst 7 days of hospital stay was associated with
TACI and diﬀuse ischemic lesions. The increased body
temperature during the ﬁrst week of hospitalization was
independently related to worse short-term and long-term
outcome, even after adjustment for in-hospital infection.
These ﬁndings lead to the conclusion that increased body
temperature during the acute phase of IS should be reduced
as soon as possible, in order to improve patients’ prognosis.
It seems interesting that, in the analysed group of IS
patients, the highest risk of developing pneumonia or UTI
during hospitalization was noticed in older females as well
as in patients with coexisting cardiovascular risk factors like
atrial ﬁbrillation, heart failure, CAD, and diabetes, as well as
in those with a history of prestroke infection. It suggests that
such patients require a particularly careful prevention and
early detection of infectious diseases.
Whenanalysingtheantibacterialtreatmentinthestudied
population, our results are not optimistic. The therapy with
antibiotics during hospitalization in patients with pneumo-
nia had no signiﬁcant impact on the outcome. In the group
of patients with UTI, an unfavourable eﬀect of antibacterial
treatment on short-term outcome (death/dependency) was
observed. It seems surprising; however, it may be probably
partially explained by the fact that UTI occurs often in
patientscatheterised,soinaworseglobalcondition.Thelack
of favourable eﬀect of antibacterial therapy on IS outcome
indicates that prophylaxis of nosocomial pneumonia or UTI
is important, as it may improve patients’ outcome.
We acknowledge that our study has several limitations.
First, we did not analyse the pre- and post-stroke antibac-
terial therapy in detail (including the type of antibiotics,
dose, and duration of treatment, as well as the time of
implementation of antibiotics after IS onset). When con-
sidering post-stroke antibacterial treatment, typically, in our
department, in patients with symptoms of pneumonia the
antibioticsofwidetherapeuticalspectrumareusedandthen,
after detection of the pathogen, speciﬁc classes of antibiotics
are implemented. However, it could not be excluded that
some patients might have pneumonia of the viral etiology,
but because of their poor condition they were also treated
with antibiotics. It might potentially inﬂuence our ﬁndings
concerning the eﬀects of antibacterial therapy.
Furthermore, when analyzing the impact of prestroke
infections on the outcome, we focused on acute infection
symptoms present during the 7 days before stroke onset. It is
obviousthatinfectionspotentiallyrelatedtostrokecanoccur
up to several weeks prior to stroke onset; however, the major
eﬀecton stroke risk seemsto have infections occuring during
the preceding week [33].
5. Conclusions
Pre- and post-stroke infections, particularly those occurring
during hospitalization, are associated with a worse IS prog-
nosis. The increase of body temperature during ﬁrst 7 days
after IS, even in patients without detected infection, has an
adverse impact on their short-term and long-term outcome.
The treatment with antibiotics during hospitalization in IS
patients has no evident beneﬁcial eﬀect; this issue should be
further investigated. The importance of prevention of pneu-
monia and UTI in patients with IS should be emphasized.
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